Matthew Hammond

Engages in the exploration and evaluation of iron ore projects

Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products

Develops and manufactures light detection and sensors & dimensional sensing solutions

Provides brokerage services

Functions as a College/University

Engages in the exploration of ocean floor for copper, gold, silver and zinc deposits activities

Operates as a holding company that provides payment processing, financial and digital token infrastructure services

Operates communication and social platforms

Part of ESSA Pharma, Inc., Realm Therapeutics, Inc. is a company that specializes in precision brain stimulation therapies to address memory loss caused by brain injury and degenerative diseases such as Alzheimer's. The company is based in Radnor, PA. The company's technology, developed at the University of Pennsylvania with DARPA funding, aims to enhance memory, reduce disability, and boost productivity for patients. By utilizing artificial intelligence to analyze brain activity patterns, the company's device delivers personalized stimulation to improve memory performance. The company is currently in the preclinical testing phase and is preparing for FDA approval to conduct clinical trials for patients with memory loss from traumatic brain injury.